Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

GLP-1 AND CIRRHOSIS: EFFECTS ON MORTALITY AND LIVER-RELATED COMPLICATIONS.

Arquivos de gastroenterologia·2026
Same author

Reevaluating the role of routine colonoscopy after acute diverticulitis: impact on colon cancer and advanced adenoma detection across age groups.

Proceedings (Baylor University. Medical Center)·2026
Same author

Differential Biliary Adverse Event Signals Among Glp-1 Receptor Agonists: A FAERS Disproportionality Analysis.

Digestive diseases and sciences·2026
Same author

THREE-MONTH OUTCOMES OF ISCHEMIC COLITIS IN ANOREXIC VS NON-ANOREXIC PATIENTS: A PROPENSITY-MATCHED COHORT STUDY.

Arquivos de gastroenterologia·2026
Same author

Does aspirin worsen Crohn's disease outcomes? A multicenter propensity-matched cohort study.

Proceedings (Baylor University. Medical Center)·2026
Same author

Endoscopic Ultrasound as a Diagnostic Tool in Obscure Gastrointestinal Bleeding: Left Gastric Artery Pseudoaneurysm Mimicking Gastric Varices.

ACG case reports journal·2026
Same journal

THE IL-6/IL-10 INFLAMMATORY AXIS AND PROGNOSIS OF CIRRHOSIS-ASSOCIATED HEPATOCELLULAR CARCINOMA: A NARRATIVE REVIEW.

Arquivos de gastroenterologia·2026
Same journal

EVALUATION OF CLINICAL ASPECTS OF PATIENTS UNDERGOING SACRAL NEUROMODULATION FOR FECAL INCONTINENCE: A RETROSPECTIVE MULTICENTER STUDY.

Arquivos de gastroenterologia·2026
Same journal

TRENDS AND RESEARCH FRONTIERS ON GUT MICROBIOTA AND STUNTING: A BIBLIOMETRIC INSIGHT FROM 2009 TO 2025.

Arquivos de gastroenterologia·2026
Same journal

MODULATING OXIDATIVE STRESS AND INFLAMMATION: SODIUM BUTYRATE'S THERAPEUTIC PROMISE IN EXPERIMENTAL COLITIS.

Arquivos de gastroenterologia·2026
Same journal

ACCURACY OF ULTRASOUND FOR SARCOPENIA ASSESSMENT IN DIGESTIVE TRACT CANCER PATIENTS.

Arquivos de gastroenterologia·2026
See all related articles

Related Experiment Video

Updated: May 21, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

THE DOUBLE BURDEN OF CIRRHOSIS AND ACUTE PANCREATITIS: AMPLIFIED RISKS FOR NUTRITIONAL AND GASTROINTESTINAL

Chidera N Onwuzo1, Kikunlore Elijah Odunsanya2, Fnu Alvina1

  • 1SUNY Upstate Medical University, Resident Physician, Syracuse, NY, USA.

Arquivos De Gastroenterologia
|May 19, 2026
PubMed
Summary
This summary is machine-generated.

Cirrhosis significantly increases risks of malnutrition, ileus, and small bowel obstruction in acute pancreatitis (AP) patients. Proactive management is crucial for this high-risk group, though pseudocyst formation may be less frequent.

Related Experiment Videos

Last Updated: May 21, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Area of Science:

  • Gastroenterology and Hepatology
  • Clinical Research
  • Patient Outcomes

Background:

  • Cirrhosis and acute pancreatitis (AP) are serious conditions that, when co-occurring, elevate morbidity and mortality risks.
  • Patients with both cirrhosis and AP face heightened vulnerability to systemic complications, including gastrointestinal dysfunction and malnutrition.

Purpose of the Study:

  • To investigate the 1-year impact of cirrhosis on outcomes in patients with AP.
  • To specifically assess the influence of cirrhosis on pseudocyst formation, protein-calorie malnutrition, ileus, small bowel obstruction, and the requirement for nutritional support.

Main Methods:

  • A retrospective cohort analysis utilized the TriNetX database to compare AP patients with and without cirrhosis.
  • Propensity score matching created balanced cohorts (26,160 patients each) for robust comparison.
  • One-year outcomes, including pseudocyst formation, ileus, small bowel obstruction, malnutrition, and nutritional interventions, were analyzed using Kaplan-Meier estimates and hazard ratios.

Main Results:

  • Cirrhosis was associated with a doubled incidence of protein-calorie malnutrition (5.2% vs. 2.6%) and significantly higher risks of ileus (2.7% vs. 1.7%) and small bowel obstruction (P<0.001).
  • The need for total parenteral nutrition (TPN) was more frequent in cirrhotic patients (1.9% vs. 1.2%).
  • Conversely, pseudocyst formation was less frequent in the cirrhosis cohort (2.3% vs. 2.8%, P=0.018).

Conclusions:

  • Cirrhosis exacerbates the risk of nutritional deficiencies, ileus, and small bowel obstruction in AP patients.
  • Multidisciplinary management strategies are essential for this vulnerable population.
  • The observed decrease in pseudocyst formation in cirrhotic patients may indicate altered AP progression.